Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention

Table 4

Percutaneous intervention findings of patients with normal reflow and no-reflow.

Parameters	Normal reflow ()	No-reflow ()	value
Time from onset of symptoms to reperfusion (hour)	5.20 ± 2.70	5.29 ± 1.95	0.315
Time from onset of symptoms to reperfusion (>6 hours)	96 (31.5)	16 (28.6)	0.666
Multivessel disease, n (%)
Yes	76 (24.9)	14 (25.0)	0.990
No	229 (75.1)	76 (24.9)
Initial TIMI flow grade, n (%)
0-1	192 (63)	38 (67.9)	0.483
≥2	113 (37.1)	18 (32.1)
Multistent, n (%)
Yes	93 (30.5)	16 (28.6)	0.774
No	212 (69.5)	40 (71.4)
IRA, n (%)
LAD	140 (45.9)	34 (60.7)	0.051
LCX	30 (9.8)	7 (12.5)
RCA	135 (44.3)	15 (26.8)
Infarct location, n (%)			0.149
Anterior wall	140 (45.9)	36 (64.3)
Inferior wall	55 (18)	6 (10.7)
Inferior and posterior wall	43 (14.1)	4 (7.1)
Complicate by right ventricular	63 (20.7)	10 (17.9)
Others	4 (1.3)	0 (0)
Aspiration thrombectomy
Yes	206 (67.5)	40 (71.4)	0.566
No	99 (32.5)	16 (28.6)
Upfront intracoronary GPIIb/IIIa receptor inhibitor
Yes	48 (15.7)	3 (5.4)	0.040
No	257 (84.3)	53 (94.6)
Non-IRA intervention, n (%)
Yes	18 (5.9)	4 (7.1)	0.760
No	287 (94.1)	52 (92.9)